Cargando…
Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis
Dissecting the molecular landscape of fibrotic disease, a major unmet need, will inform the development of novel treatment strategies to target disease progression and identify desperately needed therapeutic targets. Here, we provide a detailed single-cell analysis of the immune landscape in Dupuytr...
Autores principales: | Izadi, David, Layton, Thomas B., Williams, Lynn, McCann, Fiona, Cabrita, Marisa, Espirito Santo, Ana I., Xie, Weilin, Fritzsche, Marco, Colin-York, Huw, Feldmann, Marc, Midwood, Kim S., Nanchahal, Jagdeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892635/ https://www.ncbi.nlm.nih.gov/pubmed/31840071 http://dx.doi.org/10.1126/sciadv.aay0370 |
Ejemplares similares
-
Single cell force profiling of human myofibroblasts reveals a biophysical spectrum of cell states
por: Layton, Thomas B., et al.
Publicado: (2020) -
Author Correction: Cellular census of human fibrosis defines functionally distinct stromal cell types and states
por: Layton, Thomas B., et al.
Publicado: (2020) -
Cellular census of human fibrosis defines functionally distinct stromal cell types and states
por: Layton, Thomas B., et al.
Publicado: (2020) -
Identifying collagen VI as a target of fibrotic diseases regulated by CREBBP/EP300
por: Williams, Lynn M., et al.
Publicado: (2020) -
Recent advances in the understanding of Dupuytren’s disease
por: Layton, Thomas, et al.
Publicado: (2019)